RBC Global Asset Management Inc. announced February 2026 cash distributions for unitholders of ETF Series of RBC Funds. The RBC Canadian Equity Income Fund – ETF Series (RCEI) will distribute $0.0647 per unit to unitholders of record on March 6, 2026, with payments due on March 13, 2026.

Brompton Split Banc Corp. announced a treasury offering of preferred shares priced at $10.40 per share to yield 6.0%, with a sales period ending February 27, 2026 and expected closing on March 6, 2026. The preferred shares offer fixed quarterly distributions of $0.15625 per share and approximately 55% downside protection based on the fund's portfolio of Canada's six largest banks.

Royal Bank of Canada announced that its board of directors has declared a quarterly common share dividend of $1.64 per share, payable on or after May 22, 2026, to shareholders of record on April 23, 2026. The bank also declared dividends for various Non-Cumulative First Preferred Shares.

A class action lawsuit has been filed against Canadian Imperial Bank of Commerce (CIBC) and Royal Bank of Canada (RBC) alleging they engaged in market manipulation by placing spoofed sell orders to artificially deflate Quantum Biopharma Ltd. stock prices, then purchasing shares at depressed levels for profit. Investors who sold Quantum securities between January 6, 2021 and October 15, 2025 are encouraged to join the case.

Dividend Select 15 Corp. announced its monthly distribution of $0.06133 per Equity share, payable March 10, 2026 to shareholders of record as of February 27, 2026. The distribution is based on a 10% annualized yield calculated using the volume-weighted average market price (VWAP) of $7.36 over the last three trading days of February. Since inception, shareholders have received cumulative distributions of $11.57 per share.

Pomerantz Law Firm has filed class action lawsuits against Quantum Biopharma Ltd. and other companies for alleged securities fraud and market manipulation. The complaint alleges that CIBC World Markets, RBC Dominion Securities, and Royal Bank of Canada engaged in spoofed sell orders to artificially depress Quantum's stock price, allowing them to purchase shares at depressed levels while deceiving other investors.

Brompton Split Banc Corp. announced a 20% stock split of its Class A shares, with shareholders receiving 20 additional shares for every 100 held. The Fund will maintain monthly distributions at $0.10 per share post-split, resulting in a ~20% increase in total distribution dollars. The announcement reflects strong 10-year performance with 20.3% annualized returns, outperforming major Canadian bank and composite indices.

A class action lawsuit has been filed against Canadian Imperial Bank of Commerce (CIBC) and Royal Bank of Canada (RBC) alleging they engaged in spoofing and market manipulation schemes to artificially deflate the price of Quantum Biopharma Ltd. securities between January 2021 and October 2025. The defendants allegedly placed thousands of false sell orders to deceive investors into selling shares at depressed prices, then purchased shares at these artificially low levels for profit. Investors who sold Quantum shares during the class period are encouraged to join the lawsuit.

RBC Global Asset Management Inc. announced February 2026 cash distributions for RBC ETF unitholders. Unitholders of record on February 20, 2026, will receive distributions payable on February 27, 2026. The announcement covers various RBC ETFs including bond index funds, U.S. corporate bond ETFs, and Canadian bank yield index ETFs.

A class action lawsuit has been filed against Canadian Imperial Bank of Commerce (CIBC) and Royal Bank of Canada (RBC) alleging they engaged in spoofing and market manipulation schemes to artificially deflate the price of Quantum Biopharma Ltd. securities between January 2021 and October 2025. The defendants allegedly placed thousands of false sell orders to deceive investors into selling shares at depressed prices, then purchased shares at these artificially low levels for profit. Investors who sold Quantum shares during the class period are encouraged to join the lawsuit.

The Vanguard International High Dividend Yield ETF (VYMI) has surged 41% since the start of 2025, significantly outperforming the S&P 500's 18% gain. The ETF focuses on international dividend-paying companies across developed and emerging markets, offering a 3.4% current yield (averaging 4.1% since early 2025)—more than three times the S&P 500 average. While recommended as a diversification tool, experts suggest keeping the bulk of investments in U.S. stocks (around 90%) with international holdings as a portfolio cushion.

A class action lawsuit has been filed against Canadian Imperial Bank of Commerce (CIBC) and Royal Bank of Canada (RBC) for allegedly executing manipulative trades designed to artificially deflate the stock price of Quantum Biopharma Ltd. The defendants allegedly placed spoofed sell orders to deceive investors into selling shares at artificially depressed prices, which they then purchased at the lower levels. The class period covers January 6, 2021 to October 15, 2025, and investors have until February 23, 2026 to request lead plaintiff status.